Clinical Trial Update: A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is enrolling to evaluate LBL-024 with etoposide and platinum in patients with advanced neuroendocrine carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Carcinoma

Drugs mentioned

• Etoposide (Etoposide)
• LBL-024
• Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: Nanjing Leads Biolabs Co.,Ltd | Conditions: Advanced Neuroendocrine Carcinoma | Phase 1, Phase 2 | Status: RECRUITING